Indirubin-5-sulfonate is an inhibitor of cyclin-dependent kinases (CDKs), with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM, and 65 nM against CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, and CDK5/p35, respectively; it also inhibits GSK-3β activity.